Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2020 2
2021 8
2022 6
2023 5
2024 4
2025 13
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for athens abdi
Search for Athena Abdi instead (2 results)
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.
GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators; Rautalin I, Volovici V, Stark BA, Johnson CO, Kaprio J, Korja M, Krishnamurthi RV, Nair BS, Ranta A, Rinkel GJE, Vergouwen MDI, Abate YH, Abbastabar H, Abd-Allah F, Abdelkader A, Abdi P, Abdollahi A, Abdullahi A, Abiodun OO, Aboagye RG, Abouzid M, Abtahi D, Abu Rumeileh S, Abualhasan A, Abualruz H, Abukhadijah HJ, Abu-Zaid A, Adamu LH, Addo IY, Adedoyin RA, Adegboye OA, Adra S, Adzigbli LA, Agyemang-Duah W, Ahinkorah BO, Ahmad A, Ahmad D, Ahmadzade AM, Ahmed A, Ahmed H, Ahmed SA, Aji B, Al-Kaif MA, Al-Ajlouni Y, Al-Aly Z, Albashtawy M, Ali MU, Alif SM, Alimohamadi Y, Aljunid SM, Alomari MA, Alrawashdeh A, Alsabri MA, Salman RA, Altaf A, Al-Tammemi AB, Alvis-Guzman N, Alwafi H, Al-Wardat M, Al-Worafi YM, Aly H, Alyahya MSI, Alzoubi KH, Amani R, Amin TT, Amindarolzarbi A, Amusa GA, Anderlini D, Angappan D, Anil A, Anuoluwa BS, Anwar S, Anyasodor AE, Apostol GLC, Arabloo J, Areda D, Ärnlöv J, Artamonov AA, Artanti KD, Arumugam A, Aryan Z, Asghari-Jafarabadi M, Ashemo MY, Ashraf T, Athar M, Athari SS, Aujayeb A, Awotidebe AW, Azadnajafabad S, Aziz S, Azzam AY, Babu GR, Bagheri N, Bahrami Taghanaki P, Bahramian S, Bai … See abstract for full author list ➔ GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators, et al. JAMA Neurol. 2025 Aug 1;82(8):765-787. doi: 10.1001/jamaneurol.2025.1522. JAMA Neurol. 2025. PMID: 40406922 Free PMC article.
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.
Grande E, Bellmunt J, Hussain SA, Al Mansour MM, Bamias A, Barthélémy P, Benjamin DJ, Blais N, Bourlon MT, Castellano D, Danchaivijitr P, Fernandez Lazzaro M, Giannatempo P, Guerrero-Ramos F, Iacovelli R, Ivanyi P, Jung EH, Kanesvaran R, Manneh R, Marinho JC, Matsubara N, Merseburger AS, Mukherji D, Park CH, Tran B, da Trindade KM, Ürün Y, Kamat AM, Birtle AJ. Grande E, et al. Oncologist. 2025 Oct 1;30(10):oyaf333. doi: 10.1093/oncolo/oyaf333. Oncologist. 2025. PMID: 41052287 Free PMC article.
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.
Abdi IY, Sudhakaran IP, Ghanem SS, Vaikath NN, Majbour N, Goh YY, Vijiaratnam N, Girges C, Constantinides VC, Kapaki E, Paraskevas GP, Weber S, Adeli G, Vekrellis K, Erskine D, Hu M, Foltynie T, Houlden H, Parkkinen L, van de Berg WD, Mollenhauer B, Schlossmacher MG, El-Agnaf OM. Abdi IY, et al. J Parkinsons Dis. 2025 Dec;15(8):1412-1430. doi: 10.1177/1877718X251379292. Epub 2025 Oct 3. J Parkinsons Dis. 2025. PMID: 41042913 Free PMC article.
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study.
Bourlon MT, Galli L, Grande E, Park SH, Melichar B, Schieber TJ, Juan-Fita MJ, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, De Giorgi U, Kucharz J, Pérez Calabuig E, Conteduca V, Taha T, Rescigno P, Abu-Sini H, Spinelli GP, Manneh Kopp R, Salfi A, Bhuva D, Valdez-Sandoval P, Mendez-Bribiesca S, Fiala O, Buti S, Marques Monteiro FS, Bamias A, Ghosn M, Massari F, Ansari J, Santoni M. Bourlon MT, et al. Front Oncol. 2025 Jul 25;15:1605282. doi: 10.3389/fonc.2025.1605282. eCollection 2025. Front Oncol. 2025. PMID: 40786505 Free PMC article.
42 results